株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

冠動脈ステント市場:製品別、エンドユーザー別、業界分析レポート、地域別見通し、用途別可能性、競合市場シェア、予測

Coronary Stents Market Size By Product, By End-User, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 - 2024

発行 Global Market Insights Inc. 商品コード 752427
出版日 ページ情報 英文 120 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=113.01円で換算しております。
Back to Top
冠動脈ステント市場:製品別、エンドユーザー別、業界分析レポート、地域別見通し、用途別可能性、競合市場シェア、予測 Coronary Stents Market Size By Product, By End-User, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 - 2024
出版日: 2018年10月23日 ページ情報: 英文 120 Pages
概要

当レポートでは、世界の冠動脈ステント市場について調査し、市場の概要とセグメント別動向、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 調査方法

第2章 エグゼクティブサマリー

第3章 業界動向

  • 業界セグメンテーション
  • 業界動向
  • 業界影響力
  • 成長可能性分析
  • 法規制動向
  • 技術動向
  • ポーターズ分析
  • 競合環境
  • PESTEL分析

第4章 製品別市場

  • 市場シェア
  • 薬剤溶出ステント
  • ベアメタルステント
  • バイオアブソーバブル血管スキャッフォールド

第5章 エンドユーザー別市場

  • 市場シェア
  • 病院
  • 心臓センター
  • 外来外科センター
  • その他

第6章 地域別市場

  • 市場シェア
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第7章 企業プロファイル

  • Abbott
  • B. Braun Melsungen AG
  • Biosensors International Group, Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • テルモ株式会社
  • Elixir Medical Corporation
図表

Data Tables

  • TABLE 1. Coronary stent industry 360 0 synopsis, 2013 - 2024
  • TABLE 2. Global coronary stent market, 2013 - 2017 (USD Million)
  • TABLE 3. Global coronary stent market, 2018 - 2024 (USD Million)
  • TABLE 4. Global coronary stent market, by product, 2013 - 2017 (USD Million)
  • TABLE 5. Global coronary stent market, by product, 2018 - 2024 (USD Million)
  • TABLE 6. Global coronary stent market, by product, 2013 - 2017 (USD Million)
  • TABLE 7. Global coronary stent market, by product, 2018 - 2024 (USD Million)
  • TABLE 8. Global coronary stent market, by region, 2013 - 2016 (USD Million)
  • TABLE 9. Global coronary stent market, by region, 2017 - 2024 (USD Million)
  • TABLE 10. Industry impact forces
  • TABLE 11. Drug eluting stents market size, by region, 2013 - 2017 (USD Million)
  • TABLE 12. Drug eluting stents market, by region, 2018 - 2024 (USD Million)
  • TABLE 13. Bare metal stents market size, by region, 2013 - 2017 (USD Million)
  • TABLE 14. Bare metal stents market, by region, 2018 - 2024 (USD Million)
  • TABLE 15. Bioresorbable vascular scaffold (BVS) market size, by region, 2013 - 2017 (USD Million)
  • TABLE 16. Bioresorbable vascular scaffold (BVS) market, by region, 2018 - 2024 (USD Million)
  • TABLE 17. Hospitals market size, by region, 2013 - 2017 (USD Million)
  • TABLE 18. Hospitals market, by region, 2018 - 2024 (USD Million)
  • TABLE 19. Cardiac centers market size, by region, 2013 - 2017 (USD Million)
  • TABLE 20. Cardiac centers market, by region, 2018 - 2024 (USD Million)
  • TABLE 21. Ambulatory surgical centers market size, by region, 2013 - 2017 (USD Million)
  • TABLE 22. Ambulatory surgical centers market, by region, 2018 - 2024 (USD Million)
  • TABLE 23. Others market size, by region, 2013 - 2017 (USD Million)
  • TABLE 24. Others market, by region, 2018 - 2024 (USD Million)
  • TABLE 25. North America coronary stent market size, by country, 2013 - 2017 (USD Million)
  • TABLE 26. North America coronary stent market size, by country, 2018 - 2024 (USD Million)
  • TABLE 27. North America coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 28. North America coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 29. North America coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 30. North America coronary stent market size, by end-user, 2018 - 2024 (USD Million)
  • TABLE 31. U.S. coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 32. U.S. coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 33. U.S. coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 34. U.S. coronary stent market size, by end-user, 2018 - 2024 (USD Million)
  • TABLE 35. Canada coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 36. Canada coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 37. Canada coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 38. Canada coronary stent market size, by end-user, 2018 - 2024 (USD Million)
  • TABLE 39. Europe coronary stent market size, by country, 2013 - 2017 (USD Million)
  • TABLE 40. Europe coronary stent market size, by country, 2018 - 2024 (USD Million)
  • TABLE 41. Europe coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 42. Europe coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 43. Europe coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 44. Europe coronary stent market size, by end-user, 2018 - 2024 (USD Million)
  • TABLE 45. Germany coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 46. Germany coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 47. Germany coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 48. Germany coronary stent market size, by end-user, 2018 - 2024 (USD Million)
  • TABLE 49. UK coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 50. UK coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 51. UK coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 52. UK coronary stent market size, by end-user, 2018 - 2024 (USD Million)
  • TABLE 53. France coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 54. France coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 55. France coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 56. France coronary stent market size, by end-user, 2018 - 2024 (USD Million)
  • TABLE 57. Italy coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 58. Italy coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 59. Italy coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 60. Italy coronary stent market size, by end-user, 2018 - 2024 (USD Million)
  • TABLE 61. Spain coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 62. Spain coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 63. Spain coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 64. Spain coronary stent market size, by end-user, 2018 - 2024 (USD Million)
  • TABLE 65. Asia Pacific coronary stent market size, by country, 2013 - 2017 (USD Million)
  • TABLE 66. Asia Pacific coronary stent market size, by country, 2018 - 2024 (USD Million)
  • TABLE 67. Asia Pacific coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 68. Asia Pacific coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 69. Asia Pacific coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 70. Asia Pacific coronary stent market size, by end-user, 2018 - 2024 (USD Million)
  • TABLE 71. Japan coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 72. Japan coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 73. Japan coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 74. Japan coronary stent market size, by end-user, 2018 - 2024 (USD Million)
  • TABLE 75. China coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 76. China coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 77. China coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 78. China coronary stent market size, by end-user, 2018 - 2024 (USD Million)
  • TABLE 79. India coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 80. India coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 81. India coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 82. India coronary stent market size, by end-user, 2018 - 2024 (USD Million)
  • TABLE 83. Australia coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 84. Australia coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 85. Australia coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 86. Australia coronary stent market size, by end-user, 2018 - 2024 (USD Million)
  • TABLE 87. Latin America coronary stent market size, by country, 2013 - 2017 (USD Million)
  • TABLE 88. Latin America coronary stent market size, by country, 2018 - 2024 (USD Million)
  • TABLE 89. Latin America coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 90. Latin America coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 91. Latin America coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 92. Latin America coronary stent market size, by end-user, 2018 - 2024 (USD Million)
  • TABLE 93. Brazil coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 94. Brazil coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 95. Brazil coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 96. Brazil coronary stent market size, by end-user, 2018 - 2024 (USD Million)
  • TABLE 97. Mexico coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 98. Mexico coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 99. Mexico coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 100. Mexico coronary stent market size, by end-user, 2018 - 2024 (USD Million)
  • TABLE 101. MEA coronary stent market size, by country, 2013 - 2017 (USD Million)
  • TABLE 102. MEA coronary stent market size, by country, 2018 - 2024 (USD Million)
  • TABLE 103. MEA coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 104. MEA coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 105. MEA coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 106. MEA coronary stent market size, by end-user, 2018 - 2024 (USD Million)
  • TABLE 107. South Africa coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 108. South Africa coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 109. South Africa coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 110. South Africa coronary stent market size, by end-user, 2018 - 2024 (USD Million)
  • TABLE 111. Saudi Arabia coronary stent market size, by product, 2013 - 2017 (USD Million)
  • TABLE 112. Saudi Arabia coronary stent market size, by product, 2018 - 2024 (USD Million)
  • TABLE 113. Saudi Arabia coronary stent market size, by end-user, 2013 - 2017 (USD Million)
  • TABLE 114. Saudi Arabia coronary stent market size, by end-user, 2018 - 2024 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global coronary stent market, 2013 - 2024 (USD Million)
  • FIG. 3 Growth potential analysis, by product
  • FIG. 4 Growth potential analysis, by end-user
  • FIG. 5 Approval Pathway for coronary stents in the U.S.
  • FIG. 6 Approval Pathway for coronary stents in Europe
  • FIG. 7 Technology landscape
  • FIG. 8 Porter's analysis
  • FIG. 9 Strategy dashboard
  • FIG. 10 PESTEL analysis
目次
Product Code: 2966

Title:
Coronary Stents Market Size By Product (Drug Eluting Stent, Bare Metal Stent, Bioresorbable Vascular Scaffold), By End-User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, Brazil, Mexico, South Africa, Saudi Arabia), Application Potential, Competitive Market Share & Forecast, 2018 - 2024.

Coronary Stent Market will exceed USD 11.9 billion by 2024; as per a new research report.

Increasing demand for coronary stents will lead to business growth during the projected timeframe. High demand is attributable to increasing prevalence of cardiovascular diseases including coronary artery disease. According to American Heart Association, the annual cost of cardiovascular diseases by 2030 will exceed USD 1000 billion. Growing disease burden will positively impact demand for coronary stents, thereby driving industry growth during the forecast period.

Increasing geriatric population across the globe will drive coronary stent business growth in the future. According to World Health Organization (WHO), by 2050, more than 2.1 billion people will fall in the age group of 60 years and above. With increasing geriatric population, incidence rate of coronary artery disease will increase, thereby escalating demand for coronary stents and fostering market growth.

Bioresorbable vascular scaffold segment will show fastest growth rate of 7.6% during the projected timeframe, owing to high adoption rate. Increasing adoption rate is attributable to various technological advances that enhance efficiency and safety of bioresorbable coronary stents. Large number of application of bioresorbable coronary stents coupled with consistent drug delivery is major factor for segmental growth in the future.

Cardiac centers segment accounted for largest market share of USD 3,821.7 million in 2017. Growth is attributed to increased number of individuals seeking treatment for coronary artery disease in cardiac centers. Growing patient pool coupled with introduction of cutting-edge equipment will render positive impact on business growth during the forecast timeframe.

U.S. coronary stent market accounted for USD 2,331.8 million in 2017, owing to increasing incidence of chronic diseases such as cardiovascular and neurovascular disorders. Increasing prevalence of chronic disease will increase adoption of advanced coronary stents for treatment of coronary artery disease. Favorable healthcare regulations and reimbursement policies coupled with adoption of technologically advanced coronary stents will promote business growth in the future.

China coronary stent market will witness robust growth at 9.2% during the projected timeframe. High growth rate is credited to high prevalence of cardiovascular disorders. According to China Cardiovascular Diseases (CVD) report, in 2015, more than 290 million people in China suffered from cardiac disorders including coronary artery disease. This will lead to high adoption rate of coronary stents, thereby favoring business growth throughout the forecast timeline.

Prominent industries involved in Coronary Stent market are: B. Braun Melsungen AG, Abbott, Biosensors International Group, Boston Scientific Corporation, Biotronik SE & Co. KG, Medtronic plc, Meril Life Sciences, MicroPort Scientific Corporation, Terumo Corporation, and Elixir Medical Corporation. These prominent business players are focusing on strategic mergers, acquisitions and new product launch to strengthen market position. For instance, in June 2018, MicroPort Scientific Corporation announced that its product Firehawk (a rapamycin target eluting coronary stent system) gained approval form Hong Kong Hospital Authority. This approval will enable firm to expand its geographical outreach for long-term growth in future, thereby strengthening its market presence.

Table of contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definitions
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Coronary stents market industry 360 degree synopsis, 2013 - 2024
    • 2.1.1. Business trends
    • 2.1.2. Product trends
    • 2.1.3. End-user trends
    • 2.1.4. Regional trends

Chapter 3. Coronary Stents Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2013 - 2024
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Rising burden of coronary artery disease in U.S.
      • 3.3.1.2. Increasing demand for minimally invasive procedures
      • 3.3.1.3. Technological advancements in developed economies
      • 3.3.1.4. Pricing control of coronary stents in Asia Pacific region
      • 3.3.1.5. Rising geriatric population in developing economies
    • 3.3.2. Industry pitfalls & challenges
      • 3.3.2.1. Product failure and product recall
      • 3.3.2.2. Stringent regulatory scenario in developed countries
      • 3.3.2.3. Dearth of skilled healthcare professionals in developing economies
  • 3.4. Growth potential analysis
    • 3.4.1. By product
    • 3.4.2. By end-user
  • 3.5. Regulatory landscape
  • 3.6. Technology landscape
  • 3.7. Porter's analysis
  • 3.8. Competitive landscape, 2017
    • 3.8.1. Strategy dashboard
  • 3.9. PESTEL analysis

Chapter 4. Coronary Stents Market, By Product

  • 4.1. Coronary stents market share by Product, 2017 & 2024
  • 4.2. Drug eluting stents (DES)
    • 4.2.1. Market size, by region, 2013 - 2024 (USD Million)
  • 4.3. Bare metal stents (BMS)
    • 4.3.1. Market size, by region, 2013 - 2024 (USD Million)
  • 4.4. Bioresorbable vascular scaffold (BVS)
    • 4.4.1. Market size, by region, 2013 - 2024 (USD Million)

Chapter 5. Coronary Stents Market, By End-user

  • 5.1. Coronary stents market share by procedure, 2017 & 2024
  • 5.2. Hospitals
    • 5.2.1. Market size, by region, 2013 - 2024 (USD Million)
  • 5.3. Cardiac centers
    • 5.3.1. Market size, by region, 2013 - 2024 (USD Million)
  • 5.4. Ambulatory surgical centers
    • 5.4.1. Market size, by region, 2013 - 2024 (USD Million)
  • 5.5. Others
    • 5.5.1. Market size, by region, 2013 - 2024 (USD Million)

Chapter 6. Coronary Stents Market, By Region

  • 6.1. Coronary stents market share by region, 2017 & 2024
  • 6.2. North America
    • 6.2.1. Market size, by country, 2013 - 2024 (USD Million)
    • 6.2.2. Market size, by product, 2013 - 2024 (USD Million)
    • 6.2.3. Market size, by end-user, 2013 - 2024 (USD Million)
    • 6.2.4. U.S.
      • 6.2.4.1. Market size, by product, 2013 - 2024 (USD Million)
      • 6.2.4.2. Market size, by end-user, 2013 - 2024 (USD Million)
    • 6.2.5. Canada
      • 6.2.5.1. Market size, by product, 2013 - 2024 (USD Million)
      • 6.2.5.2. Market size, by end-user, 2013 - 2024 (USD Million)
  • 6.3. Europe
    • 6.3.1. Market size, by country, 2013 - 2024 (USD Million)
    • 6.3.2. Market size, by product, 2013 - 2024 (USD Million)
    • 6.3.3. Market size, by end-user, 2013 - 2024 (USD Million)
    • 6.3.4. Germany
      • 6.3.4.1. Market size, by product, 2013 - 2024 (USD Million)
      • 6.3.4.2. Market size, by end-user, 2013 - 2024 (USD Million)
    • 6.3.5. UK
      • 6.3.5.1. Market size, by product, 2013 - 2024 (USD Million)
      • 6.3.5.2. Market size, by end-user, 2013 - 2024 (USD Million)
    • 6.3.6. France
      • 6.3.6.1. Market size, by product, 2013 - 2024 (USD Million)
      • 6.3.6.2. Market size, by end-user, 2013 - 2024 (USD Million)
    • 6.3.7. Italy
      • 6.3.7.1. Market size, by product, 2013 - 2024 (USD Million)
      • 6.3.7.2. Market size, by end-user, 2013 - 2024 (USD Million)
    • 6.3.8. Spain
      • 6.3.8.1. Market size, by product, 2013 - 2024 (USD Million)
      • 6.3.8.2. Market size, by end-user, 2013 - 2024 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Market size, by country, 2013 - 2024 (USD Million)
    • 6.4.2. Market size, by product, 2013 - 2024 (USD Million)
    • 6.4.3. Market size, by end-user, 2013 - 2024 (USD Million)
    • 6.4.4. Japan
      • 6.4.4.1. Market size, by product, 2013 - 2024 (USD Million)
      • 6.4.4.2. Market size, by end-user, 2013 - 2024 (USD Million)
    • 6.4.5. China
      • 6.4.5.1. Market size, by product, 2013 - 2024 (USD Million)
      • 6.4.5.2. Market size, by end-user, 2013 - 2024 (USD Million)
    • 6.4.6. India
      • 6.4.6.1. Market size, by product, 2013 - 2024 (USD Million)
      • 6.4.6.2. Market size, by end-user, 2013 - 2024 (USD Million)
    • 6.4.7. Australia
      • 6.4.7.1. Market size, by product, 2013 - 2024 (USD Million)
      • 6.4.7.2. Market size, by end-user, 2013 - 2024 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Market size, by country, 2013 - 2024 (USD Million)
    • 6.5.2. Market size, by product, 2013 - 2024 (USD Million)
    • 6.5.3. Market size, by end-user, 2013 - 2024 (USD Million)
    • 6.5.4. Brazil
      • 6.5.4.1. Market size, by product, 2013 - 2024 (USD Million)
      • 6.5.4.2. Market size, by end-user, 2013 - 2024 (USD Million)
    • 6.5.5. Mexico
      • 6.5.5.1. Market size, by product, 2013 - 2024 (USD Million)
      • 6.5.5.2. Market size, by end-user, 2013 - 2024 (USD Million)
  • 6.6. Middle East & Africa
    • 6.6.1. Market size, by country, 2013 - 2024 (USD Million)
    • 6.6.2. Market size, by product, 2013 - 2024 (USD Million)
    • 6.6.3. Market size, by end-user, 2013 - 2024 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. Market size, by product, 2013 - 2024 (USD Million)
      • 6.6.4.2. Market size, by end-user, 2013 - 2024 (USD Million)
    • 6.6.5. Saudi Arabia
      • 6.6.5.1. Market size, by product, 2013 - 2024 (USD Million)
      • 6.6.5.2. Market size, by end-user, 2013 - 2024 (USD Million)

Chapter 7. Company Profiles

  • 7.1. Abbott
    • 7.1.1. Business overview
    • 7.1.2. Financial data
    • 7.1.3. Product landscape
    • 7.1.4. Strategic outlook
    • 7.1.5. SWOT analysis
  • 7.2. B. Braun Melsungen AG
    • 7.2.1. Business overview
    • 7.2.2. Financial data
    • 7.2.3. Product landscape
    • 7.2.4. Strategic outlook
    • 7.2.5. SWOT analysis
  • 7.3. Biosensors International Group, Ltd.
    • 7.3.1. Business overview
    • 7.3.2. Financial data
    • 7.3.3. Product landscape
    • 7.3.4. Strategic outlook
    • 7.3.5. SWOT analysis
  • 7.4. Biotronik SE & Co. KG
    • 7.4.1. Business overview
    • 7.4.2. Financial data
    • 7.4.3. Product landscape
    • 7.4.4. Strategic outlook
    • 7.4.5. SWOT analysis
  • 7.5. Boston Scientific Corporation
    • 7.5.1. Business overview
    • 7.5.2. Financial data
    • 7.5.3. Product landscape
    • 7.5.4. Strategic outlook
    • 7.5.5. SWOT analysis
  • 7.6. Medtronic plc
    • 7.6.1. Business overview
    • 7.6.2. Financial data
    • 7.6.3. Product landscape
    • 7.6.4. Strategic outlook
    • 7.6.5. SWOT analysis
  • 7.7. Meril Life Sciences Pvt. Ltd.
    • 7.7.1. Business overview
    • 7.7.2. Financial data
    • 7.7.3. Product landscape
    • 7.7.4. Strategic outlook
    • 7.7.5. SWOT analysis
  • 7.8. MicroPort Scientific Corporation
    • 7.8.1. Business overview
    • 7.8.2. Financial data
    • 7.8.3. Product landscape
    • 7.8.4. Strategic outlook
    • 7.8.5. SWOT analysis
  • 7.9. Terumo Corporation
    • 7.9.1. Business overview
    • 7.9.2. Financial data
    • 7.9.3. Product landscape
    • 7.9.4. Strategic outlook
    • 7.9.5. SWOT analysis
  • 7.10. Elixir Medical Corporation.
    • 7.10.1. Business overview
    • 7.10.2. Financial data
    • 7.10.3. Product landscape
    • 7.10.4. Strategic outlook
    • 7.10.5. SWOT analysis
Back to Top